---
title: "Piper Sandler Sticks to Their Buy Rating for Merit Medical Systems (MMSI)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285932528.md"
description: "Piper Sandler analyst Jason Bednar maintained a Buy rating on Merit Medical Systems (MMSI) with a price target of $96.00. Bednar, who focuses on the Healthcare sector, has an average return of -5.7% and a 37.06% success rate on his stock recommendations. Merit Medical also received a Buy rating from Barrington’s Michael Petusky, while Bank of America Securities reiterated a Hold rating on the same day."
datetime: "2026-05-11T10:58:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285932528.md)
  - [en](https://longbridge.com/en/news/285932528.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285932528.md)
---

# Piper Sandler Sticks to Their Buy Rating for Merit Medical Systems (MMSI)

In a report released today, Jason Bednar from Piper Sandler reiterated a Buy rating on Merit Medical Systems, with a price target of $96.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Bednar covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, ICU Medical, and NovoCure. According to TipRanks, Bednar has an average return of \-5.7% and a 37.06% success rate on recommended stocks.

In addition to Piper Sandler, Merit Medical Systems also received a Buy from Barrington’s Michael Petusky in a report issued on May 1. However, on the same day, Bank of America Securities reiterated a Hold rating on Merit Medical Systems (NASDAQ: MMSI).

### Related Stocks

- [MMSI.US](https://longbridge.com/en/quote/MMSI.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [ICUI.US](https://longbridge.com/en/quote/ICUI.US.md)
- [NVCR.US](https://longbridge.com/en/quote/NVCR.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [Insider Shake-Up at Merit Medical Systems as Top Executives Trade Shares](https://longbridge.com/en/news/286025578.md)
- [Merit Medical’s Revised Executive Pay Deals Raise Dilution, Governance and M&A Flexibility Concerns](https://longbridge.com/en/news/284957396.md)
- [09:00 ETMercy Names New Senior Vice President and Chief People Officer](https://longbridge.com/en/news/286775735.md)
- [LifeSci Capital Sticks to Their Buy Rating for MoonLake Immunotherapeutics (MLTX)](https://longbridge.com/en/news/286649191.md)
- [LifeSci Capital Sticks to Its Buy Rating for Neurogene (NGNE)](https://longbridge.com/en/news/286648209.md)